Table 1 Demographic and clinical characteristics of patients.

From: Construction and validation of a nomogram for non small cell lung cancer patients with liver metastases based on a population analysis

Variables

Training cohort

Validation cohort

N = 1375

N = 588

n

%

n

%

Age

 < 55

162

11.7

89

15.1

55–66

480

35.0

200

34.0

 > 66

733

53.3

299

50.9

 > 66

733

   

Race

Black

144

10.5

57

9.7

Other

158

11.5

59

10.0

White

1073

78.0

472

80.3

Sex

Male

804

58.5

338

57.5

Female

571

41.5

250

42.5

Primary site

Lower lobe

413

30.1

192

32.7

Main bronchus

63

4.6

26

4.4

Middle lobe

68

4.9

31

5.3

Overlapping lesion of lung

17

1.2

7

1.2

Upper lobe

814

59.2

332

56.4

Laterality

Left

613

44.6

213

36.2

Right

762

55.4

375

63.8

Histological types

Adenocarcinoma

752

54.7

322

54.8

Other

245

17.8

109

18.5

Squamous cell carcinoma

378

27.5

157

26.7

Grade

I

65

4.7

26

4.4

II

335

24.4

144

24.5

III

941

68.4

401

68.2

IV

34

2.5

17

2.9

T stage

T1

112

8.1

51

8.7

T2

388

28.2

156

26.5

T3

395

28.7

176

29.9

T4

480

35.0

205

34.9

N stage

No

272

19.8

115

19.6

N1

122

8.9

42

7.1

N2

691

50.2

293

49.8

N3

290

21.1

138

23.5

Surgery

No

41

3.0

568

96.6

Yes

1334

97.0

20

3.4

Chemotherapy

No

608

44.2

247

42.0

Yes

767

55.8

341

58.0

Radiotherapy

No

785

57.1

335

57.0

Yes

590

42.9

253

43.0

Bone metastasis

No

667

48.5

278

47.3

Yes

708

51.5

310

52.7

Brain metastasis

No

1004

73.0

442

75.2

Yes

371

27.0

146

24.8

Lung metastasis

No

881

64.1

384

65.3

Yes

494

35.9

204

34.7

Tumor size

 < 42

521

37.9

227

38.6

42–71

555

40.4

219

37.2

 > 71

299

21.7

142

24.2

Insurance status

    

No

45

3.3

12

2.0

Yes

1330

96.7

576

98.0

Marital

    

No

608

44.2

269

45.7

Yes

767

55.8

319

54.3